30 March 2026

---

A New Saliva Assessment Tool for Both Medical and Dental Professionals: FishburneTabs OH

---

Clinical dry mouth often goes undetected. People adjust to xerostomia¹, and drying changes may be gradual, making dry mouth (hyposalivation) a low priority for many healthcare professionals. Methods to objectively measure saliva—such as collecting drooled saliva—are unappealing to patients and staff. Yet dry mouth significantly increases the risk of oral health problems². Importantly, it is often an early indicator of systemic diseases, including autoimmune disorders and diabetes. FishburneTabs®OH by Fishburne May LLC, a consistent, rapid saliva volume indicator that is newly available, makes hyposalivation screening reliable, efficient, and easy.

Hyposalivation is associated with innumerable common medications, cannabinoids, autoimmune diseases, diabetes, and stress. For older adults, or those taking multiple medications, the risk is amplified.

FishburneTabs®OH indicate total saliva (secretions from all salivary glands) available in the mouth with a 3-minute test. Easily repeated, FishburneTabsOH are intended to show change and individual trends in saliva volume. The patented technology is based on its unique papers, a design to ensure consistent placement in the mouth, and natural capillary action. Any saliva liquid is absorbed into the paper device and remains unseen.

Invented by a dentist, FishburneTabs®OH bridge the divide between physicians and oral health professionals as a shared clinical support tool to evaluate and monitor patients in cases when systemic disease is pre-existing or suspected. Of special note, reimbursement opportunities are available through Medicare and some insurers.

Source: https://www.cardinalhealth.com/